申请人:Balter Sylvie
公开号:US20050182104A1
公开(公告)日:2005-08-18
This invention discloses and claims a compound conforming to the general formula (I):
Wherein R
1
, R
2
, R′
2
, R
3
, R
4
and R
5
are as described herein. The compounds of the present invention exhibit an inhibitory effect on the production of β-amyloid peptide (β-A4) by inhibition of gamma protease. Therefore, the compounds of the present invention are useful in the treatment of pathologies such as senile dementia, Alzheimer's disease, Down's syndrome, Parkinson's disease, amyloid angiopathy and/or cerebrovascular disorders.
本发明揭示和声明符合以下一般式(I)的化合物:其中R1、R2、R′2、R3、R4和R5如本文所述。本发明的化合物通过抑制γ蛋白酶来对β-淀粉样肽(β-A4)的产生具有抑制作用。因此,本发明的化合物在治疗老年性痴呆、阿尔茨海默病、唐氏综合征、帕金森病、淀粉样血管病和/或脑血管疾病等病理疾病方面具有用处。